Diabetic Retinopathy and Insulin Insufficiency: Beta Cell Replacement as a Strategy to Prevent Blindness
Diabetic retinopathy (DR) is a potentially devastating complication of diabetes because it puts patients at risk of blindness. Diabetes is a common cause of blindness in the U.S. and worldwide and is dramatically increasing in global prevalence. Thus new approaches are needed to prevent this dreaded...
Main Author: | Eli Ipp |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-11-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.734360/full |
Similar Items
-
Pancreatic Beta Cell Identity in Humans and the Role of Type 2 Diabetes
by: Piero Marchetti, et al.
Published: (2017-05-01) -
Emerging Roles of Metallothioneins in Beta Cell Pathophysiology: Beyond and above Metal Homeostasis and Antioxidant Response
by: Mohammed Bensellam, et al.
Published: (2021-02-01) -
Butyrate Protects Pancreatic Beta Cells from Cytokine-Induced Dysfunction
by: Michala Prause, et al.
Published: (2021-09-01) -
Emerging molecular technologies for light-mediated modulation of pancreatic beta-cell function
by: Zijing Chen, et al.
Published: (2022-10-01) -
Study of beta-cell function (by HOMA model) in metabolic syndrome
by: M K Garg, et al.
Published: (2011-01-01)